BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210709
DTEND;VALUE=DATE:20210713
DTSTAMP:20210309T184944Z
CREATED:20200908T161215Z
LAST-MODIFIED:20210309T184944Z
UID:4330-1625788800-1626134399@carb-x.org
SUMMARY:31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
DESCRIPTION:We invite you to the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)\, which will take place in Vienna\, Austria and virtually from 9 – 12 July 2021. This is the first time the event will take place in summer. ECCMID\, the world’s premier Clinical Microbiology & Infectious Diseases event\, brings together experts from relevant fields to present the latest findings and developments and share their expertise. The congress will take place in the beautiful city of Vienna at the Reed Messe Conference Centre\, as well as online\, allowing us to create a unique experience to all delegates regardless of the mode of participation. The programme committee has developed a multi-faceted programme to incorporate all of the exciting educational\, social and professional events that ECCMID has to offer. \nTo learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/31st-european-congress-of-clinical-microbiology-infectious-diseases-eccmid/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210629
DTEND;VALUE=DATE:20210702
DTSTAMP:20210420T152648Z
CREATED:20210420T152648Z
LAST-MODIFIED:20210420T152648Z
UID:5305-1624924800-1625183999@carb-x.org
SUMMARY:6th Microbiome Movement - Drug Development Summit
DESCRIPTION:Welcome to the 6th Microbiome Movement – Drug Development Summit\, the most comprehensive forum for microbiome drug developers\, the Microbiome Movement! \nContinuing to unite the most forward thinking and industry researchers from the biopharmaceutical industry\, our unrivaled program will uncover microbiome functionality and mechanisms\, advance clinical development\, overcome the key CMC challenges\, whilst also discovering and applying microbiome biomarkers for improved clinical outcomes. This is THE must attend conference for microbiome drug developers. \nRecent clinical successes within the space are paving a way for the first FDA approved microbiome therapeutic\, however\, there still remains a number of unique scientific and practical challenges that must be overcome to pursue the causal role of the microbiome in disease\, and translate the complex science into realized and effective therapies that improve patient outcomes. \nOur end-to-end discussion will unite 65+ expert speakers and 250+ key decision-makers to provide you with valuable insights into the latest scientific discoveries and industry progress\, to help overcome the obstacles holding back therapeutic approval. This summit provides unique a platform for lasting connections with leaders at the cutting edge of making microbiome therapeutics an effective reality. \nThe 6th Microbiome Movement – Drug Development Summit is the perfect opportunity for the industry to take a collaborative approach to close the clinical gap\, discover the next generation of microbiome-based therapeutics\, and establish new partnerships to accelerate your research.  \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/6th-microbiome-movement-drug-development-summit/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210620
DTEND;VALUE=DATE:20210625
DTSTAMP:20210607T161650Z
CREATED:20210127T224752Z
LAST-MODIFIED:20210607T161650Z
UID:4896-1624147200-1624579199@carb-x.org
SUMMARY:World Microbe Forum
DESCRIPTION:From new infectious pathogens like SARS-CoV-2\, to antimicrobial resistance and the role of microbes in climate change\, to agriculture and food microbiology\, and synthetic and applied microbiology – international experts will gather for World Microbe Forum to examine\, discuss and envision solutions that science can offer to solve some of the gravest concerns confronting us today. \nThis unique and special event\, a collaboration between the American Society for Microbiology (ASM) and the Federation of European Microbiological Societies (FEMS)\, is bringing together two of the biggest events in the microbial sciences\, ASM Microbe 2021 and FEMS2021\, to further science and help answer some of the most important questions impacting humankind. Additional scientific societies\, including the American Society for Virology (ASV) and the African Society for Laboratory Medicine (ASLM) will be key partners in this event. \nExplore the hottest topics in microbiology\, discussed like never before\, and offering unparalleled access to the latest innovative research across global perspectives. Create meaningful connections with peers from around the world. Be a part of this first-of-its-kind virtual meeting uniting the microbial sciences community.  \nCARB-X participants include Erin Duffy\, Chief of R&D\, who will join a panel focused on “Advancing Collaborations in the Global Fight Against AMR and Pandemics” on June 21st from 11am to 12:30pm ET. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/world-microbe-forum/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210427
DTEND;VALUE=DATE:20210429
DTSTAMP:20210420T152022Z
CREATED:20210420T152022Z
LAST-MODIFIED:20210420T152022Z
UID:5304-1619481600-1619654399@carb-x.org
SUMMARY:BactiVac Online: Virtual Network Conference 2021
DESCRIPTION:Delivering our 2021 Virtual Network Conference in an innovative online format will provide a unique opportunity to hear about the latest bacterial vaccinology research from leading international researchers in a safe environment. Talks will be delivered by a host of internationally renowned speakers from a range of disciplines\, all actively involved in the research area of bacterial vaccinology. Please view the programme for our virtual conference\, together with speaker profiles. \nThe conference is open and free to attend for BactiVac Network members only and booking is compulsory; you can apply for free membership here. Registration for the conference is now closed. \nKeep up to date by following us on @BactiVac\, using #BactiVacEvents. You can also download BactiVac Virtual Conference flyer to circulate and/or display within your organisation. \nFor any queries regarding virtual conference\, please contact us at: bactivac@contacts.bham.ac.uk \nClick here to learn more.
URL:https://carb-x.org/event/bactivac-online-virtual-network-conference-2021/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210423
DTEND;VALUE=DATE:20210424
DTSTAMP:20210317T173524Z
CREATED:20200916T175807Z
LAST-MODIFIED:20210317T173524Z
UID:4352-1619136000-1619222399@carb-x.org
SUMMARY:Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea; Public Workshop
DESCRIPTION:FDA\, NIAID and CDC are announcing a public workshop regarding the development considerations of antimicrobial drugs for the treatment of gonorrhea. The workshop will focus on the current state and nonclinical and clinical trial design considerations regarding antimicrobial drug development for gonorrhea and include the following topic areas: \n\nAnimal models\nClinical pharmacology considerations\nTrial design considerations for gonorrhea\, such as enrollment strategies\, choice of comparators and site of infection.\n\nThis meeting will be held in virtual format only. Registration is required for online attendance. \nTo learn more\, click here.\nAdditional details forthcoming.
URL:https://carb-x.org/event/development-considerations-of-antimicrobial-drugs-for-the-treatment-of-gonorrhea-public-workshop/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210423
DTSTAMP:20201221T211322Z
CREATED:20201221T211322Z
LAST-MODIFIED:20201221T211322Z
UID:4833-1618876800-1619135999@carb-x.org
SUMMARY:Anti-Infectives Drug Development Summit
DESCRIPTION:Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater\, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments\, biopharma\, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. \nWith some now considering the field as the new ‘Wall Street darling’\, especially given the $1 billion launch of the AMR action fund\, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs. \nBringing together 60+ senior leaders from large pharma\, innovative biotech\, academia and investment companies\, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates\, novel modalities and effective strategies\, that address market sustainability and aim for superiority. \nHere is a sneak peak of the world-class speaker faculty: \n\nCara Cassino\, Executive Vice President of R&D & Chief Medical Officer\, ContraFect\nKevin Outterson\, Executive Director\, CARB-X\nSilas Holland\, Head of External Affairs (Interim) & Director of Global Policy\, Merck & The AMR Action Fund\nDavid Powell\, Chief Scientific Officer\, Summit Therapeutics\nDave Ousterout\, Chief Scientific Officer\, Locus Biosciences\nAngela Talley\, Vice President of Clinical Development\, Spero Therapeutics\nErcem Atillasoy\, Chief Regulatory & Safety Officer\, AlloVir\nDavid Alterac\, Chief Medical Officer\, Entasis Therapeutics\n\nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/anti-infectives-drug-development-summit-2/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201208
DTEND;VALUE=DATE:20201211
DTSTAMP:20220803T215834Z
CREATED:20201112T203844Z
LAST-MODIFIED:20220803T215834Z
UID:4573-1607385600-1607644799@carb-x.org
SUMMARY:BLUE KNIGHT™ Symposium
DESCRIPTION:CARB-X participants include Erin Duffy\, Chief of R&D. \nJohnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA)\, a component of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services\, to form Blue Knight. This collaboration aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases. Find out more about BARDA and its mission at www.PHE.gov/BARDA. \nIn seeking to combat emerging infectious diseases and other 21st century health threats\, the path to better prepared\, protected\, and healthy individuals\, families\, and communities could rely on unlocking the collective power of the global community. BLUE KNIGHT™ seeks to answer this call. \nOn December 8-10\, Johnson & Johnson Innovation – JLABS and BARDA will virtually convene the emerging Blue Knight community of thought leaders\, innovators and entrepreneurs for a three-day symposium\, including interactive sessions focused on key areas of interest in infectious disease\, public health\, and company acceleration. Sessions will explore high priority areas of interest for scientific and technological innovation aimed for improving our preparedness and response to emerging health security threats. \nTo learn more\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/blue-knight-symposium/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201203T030000
DTEND;TZID=America/New_York:20201203T043000
DTSTAMP:20201112T205113Z
CREATED:20201112T205113Z
LAST-MODIFIED:20201112T205113Z
UID:4572-1606964400-1606969800@carb-x.org
SUMMARY:Evidence to Action Webinar: Advancing the Antimicrobial Resistance agenda during a pandemic
DESCRIPTION:How can efforts to implement Antimicrobial Resistance National Action Plans still progress despite the COVID-19 pandemic? \nThere is no doubt COVID-19 currently represents the most obvious and urgent issue for global health security and the world is rightfully focused on tackling this pandemic. However\, the challenges posed by COVID-19 are only a foretaste of what antimicrobial resistance (AMR) can mean to the world without appropriate interventions. AMR\, the silent pandemic\, can impact many of the global health achievements of past decades and jeopardize efforts to deliver on many of the Sustainable Development Goals. \nThis webinar provides an opportunity to gain insights into current efforts to continuously move forward the agenda of combatting AMR amidst the COVID-19 pandemic. Key experts and opinion leaders will share their strategic reflections and insights focusing on what evidence and data are currently available and how best to leverage them into action to tackle AMR\, especially in low- and middle-income countries. \nThis event is co-hosted by the International Vaccine Institute (IVI)\, the International Centre for Antimicrobial Resistance Solutions (ICARS) and the Embassy of Denmark in Korea. Speakers from IVI\, ICARS\, WHO and the UK will lead the panel discussion. Please join the conversation and ask questions to our panel. \nTo learn more\, click here. \nTo register\, click here.\nPlease note that registration is required\, and a link to webinar will be shared in advance to registered attendees \nDecember 3\, 2020\n9:00-10:30 AM (CET); 5:00-6:30 PM (KST); 3:00-4:30 AM (EST)
URL:https://carb-x.org/event/evidence-to-action-webinar-advancing-the-antimicrobial-resistance-agenda-during-a-pandemic/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201130
DTEND;VALUE=DATE:20201204
DTSTAMP:20200924T152007Z
CREATED:20200924T152007Z
LAST-MODIFIED:20200924T152007Z
UID:4410-1606694400-1607039999@carb-x.org
SUMMARY:World Vaccine and Immunotherapy Congress West Coast 2020
DESCRIPTION:In December 2019 SARS-CoV-2 the cause of COVID-19\, was responsible for thousands of deaths in Wuhan\, China. By March 11\, 2020\, WHO declared COVID-19 as a worldwide pandemic.The single most effective way to tackle this pandemic is a working vaccine\, which is why Vaccine Congress West Coast is bringing together experts who have been working tirelessly to make this happen\, in a safe\, virtual environment. This is the most important meeting you will be part of. Now more than ever\, we need everyone’s contribution to solve this global problem. \nCome together and join us VIRTUALLY to identify the urgent priorities for research. To mobilize\, coordinate and align funding to enable the research needed to tackle this crisis and stop the outbreak\, and commit with our experts how you can learn mechanisms for continuing scientific interactions and collaborations\, now and beyond the congress. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/world-vaccine-and-immunotherapy-congress-west-coast-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201119T090000
DTEND;TZID=America/New_York:20201119T100000
DTSTAMP:20200924T151233Z
CREATED:20200924T151233Z
LAST-MODIFIED:20200924T151233Z
UID:4408-1605776400-1605780000@carb-x.org
SUMMARY:Antimicrobial Resistance Fighter Coalition Webinar: Responding to difficult-to-treat infections: Role and responsibilities of governments\, researchers\, clinicians\, industry and patients
DESCRIPTION:AMR in the Light of COVID-19 – A Webinar Series\nEach of us is now living in a world with a nearly untreatable virus – but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to kill them. COVID-19 foreshadows a grim future if we do not mobilize a global response to the growing threat of antimicrobial resistance (AMR). Through a four-part series\, global experts will discuss how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world. \nAbout this Webinar:\nGovernments\, researchers\, and industry partners around the world have mobilized to develop diagnostics\, therapeutics\, and vaccines for COVID-19. The development of new recommendations and practices continue to be deployed to slow the spread of COVID-19. The burden of drug-resistant infections could surpass COVID-19. Drugs like antibiotics are a vital tool for modern medicine\, used to prevent and treat infections. As drug-resistant infections are becoming more common\, modern medicine as we know it is at risk and much like COVID-19\, it has the potential to overwhelm our healthcare structure. What changes are needed to reshape strategies for combatting antimicrobial resistance globally? \nTo learn more about the Antimicrobial Resistance Fighter Coalition\, click here.\nTo learn more about this webinar series\, click here.\nTo register for this webinar\, click here.
URL:https://carb-x.org/event/antimicrobial-resistance-fighter-coalition-webinar-responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-clinicians-industry-and-patients-2/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20201118T093000
DTEND;TZID=Europe/Amsterdam:20201118T174500
DTSTAMP:20201112T205559Z
CREATED:20201110T160522Z
LAST-MODIFIED:20201112T205559Z
UID:4561-1605691800-1605721500@carb-x.org
SUMMARY:Emerging Antimicrobials and Diagnostics in AMR 2020
DESCRIPTION:CARB-X participants include Nadia Cohen\, Alliance Manager\, who will present during the Accelerating AMR R&D section of the program at 10:40 EST\, and Betsy Wonderly Trainor\, Alliance Director\, who will present at 10:20 EST. \nLearn about the latest AMR technologies in a series of interactive key note lectures by international Captains of Industry and Leading Scientists. \nInteractive\, one day online event providing an international podium for emerging preventives\, antimicrobial strategies\, microbial diagnostics and related (platform) technologies: key note lectures\, technology and product updates\, frontline stories and concluding Q&A session. \nThe event is composed of 3 building sections:\nI: Setting the scene of AMR R&D (09:30 – 12:30 AM)\nII: Technology and Product Updates in AMR (01:00 – 03:50 PM)\nIII: Accelerating AMR R&D (04:00 – 05:45 PM). \nDate: 18 November\, 2020; 09:30 AM – 05:45 PM CET\nThe event is delivered digitally in collaboration with KIT Royal Tropical Institute in Amsterdam and marks the beginning of the World Antimicrobials Awareness Week. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/emerging-antimicrobials-and-diagnostics-in-amr-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201118
DTEND;VALUE=DATE:20201125
DTSTAMP:20201110T184941Z
CREATED:20201110T184941Z
LAST-MODIFIED:20201110T184941Z
UID:4564-1605657600-1606262399@carb-x.org
SUMMARY:World Antimicrobial Awareness Week 2020
DESCRIPTION:The theme for World Antimicrobial Awareness Week 2020 for the human health sector is “United to preserve antimicrobials.” \nEvery year\, World Antimicrobial Awareness Week aims to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices among the general public\, health workers and policy makers to stop the further emergence and spread of drug-resistant infections. \nWAAW has expanded its scope to address not just antibiotics\, but all antimicrobials\, including antiviral\, antifungal and antiparasitic medicines. This exciting decision came on the strong recommendation of the antimicrobial resistance (AMR) community. In the midst of a global pandemic\, stakeholders came together virtually to discuss the challenges and opportunities for the WAAW campaign and awareness of Antimicrobial Resistance (AMR) more generally. The overarching message was that all sectors needed to unite to change behaviours and that the campaign needed to broaden its scope from antibiotics\, to include all antimicrobials. \nFor the first time ever\, we are also celebrating WAAW at a time when traditional methods of campaigning are not possible. We are challenged by new rules of social distancing\, limitations on public gatherings\, and physical isolation. As with the global virtual consultation in May 2020\, however\, the AMR community has shown its commitment\, resilience and eagerness to celebrate\, unite\, and build awareness around an issue that is becoming one of the most significant challenges to our global health and development objectives. Over the 7 days of WAAW 2020\, events will be held virtually in all regions of the world\, by governments\, academics\, students\, health care workers\, NGOs and all those interested and passionate about combating AMR. \nTo learn more\, click here.
URL:https://carb-x.org/event/world-antimicrobial-awareness-week-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201028
DTSTAMP:20201020T143659Z
CREATED:20200908T160156Z
LAST-MODIFIED:20201020T143659Z
UID:4326-1603756800-1603843199@carb-x.org
SUMMARY:BARDA Industry Day
DESCRIPTION:BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities\, interact with BARDA and ASPR staff\, and network with public and private sector colleagues working in the Health Security space. This year\,  BARDA Industry Day 2020 will be virtual and will feature one day of exciting speakers\, breakout sessions\, and valuable networking opportunities!  The primary mission of BARDA’s industry day is to advance innovation and development of medical countermeasures\, bring together potential collaborators from across organizations\, share our accomplishments among our stakeholders\, and provide BARDA’s vision for the upcoming year’s priorities. \nBARDA\, through the CARB-X and Drive programs\, is supporting a networks of wrap-around-service-oriented accelerators that can be leveraged to prepare partners for donor funding. The hope is to fill and maintain a pipeline of partners ready and able to apply for advanced research support while bolstering the market of life-saving countermeasures. DRIVE and CARB-X will organize a panel of BARDA supported accelerators who will describe how “wrap-around services” have actually lead to better products (fitting the BID theme of ‘responding together’. At the end of the panel\, we will moderate a Q&A with audience members. Promotional material from other accelerators will be made available digitally for audience members. \nTo learn more\, click here.
URL:https://carb-x.org/event/barda-industry-day-2/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201026
DTEND;VALUE=DATE:20201030
DTSTAMP:20200908T161523Z
CREATED:20200908T155855Z
LAST-MODIFIED:20200908T161523Z
UID:4323-1603670400-1604015999@carb-x.org
SUMMARY:38th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2020)
DESCRIPTION:The 38th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2020) will be held on 26-29 October 2020 as a fully virtual meeting. \nThe organization of the meeting is a joint effort of ESPID members from the Netherlands. The ESPID forms the basis for investigators interested in infectious diseases in children and infection prevention in childhood. The main intent of the meeting is to bring together the most prominent researchers in and relevant to the field of paediatric infectious diseases and immunology. The meeting will provide an opportunity to exchange knowledge and generate new ideas in a relaxed\, smart albeit casual atmosphere. \nTo learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/38th-annual-meeting-of-the-european-society-for-paediatric-infectious-diseases-espid-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201021
DTEND;VALUE=DATE:20201026
DTSTAMP:20200908T160006Z
CREATED:20200908T155407Z
LAST-MODIFIED:20200908T160006Z
UID:4321-1603238400-1603670399@carb-x.org
SUMMARY:IDWeek 2020
DESCRIPTION:To learn more\, click here.\nTo view the program\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/idweek-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201019T040500
DTEND;TZID=America/New_York:20201019T040500
DTSTAMP:20200924T150708Z
CREATED:20200916T173318Z
LAST-MODIFIED:20200924T150708Z
UID:4341-1603080300-1603080300@carb-x.org
SUMMARY:World Vaccine Congress Europe: Changing the paradigm and finding a sustainable way to tackle AMR - The need for alternatives to antibiotics
DESCRIPTION:CARB-X speakers include Ed Buurman\, Alliance Director. \nTopics covered include: \n\nHow big is the problem economically speaking?\nShould we phase out broad-spectrum antibiotics?\nProgrammatic & technical challenges\nWhat can vaccines bring?\n\nClick here to view the agenda.\nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/world-vaccine-congress-europe-changing-the-paradigm-and-finding-a-sustainable-way-to-tackle-amr-the-need-for-alternatives-to-antibiotics/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201019
DTEND;VALUE=DATE:20201022
DTSTAMP:20200924T150127Z
CREATED:20200924T150127Z
LAST-MODIFIED:20200924T150127Z
UID:4402-1603065600-1603324799@carb-x.org
SUMMARY:5th Microbiome Movement - Drug Development Summit 2020
DESCRIPTION:The study of the human microbiome remains one of the most exciting frontiers in modern medicine that if targeted correctly\, has the potential to benefit millions of patients suffering from numerous diseases. However\, the potential for effective medicines powered by the microbiome is matched by the unique challenges in developing them. \nThe Microbiome Movement – Drug Development Summit returns as the “must attend meeting for the translational microbiome community” to help cutting-edge pharmaceutical and academic researchers pursue the causal role of the human microbiome in disease to help deliver a new generation of targeted therapeutics\, biomarker and diagnostics that demonstrate consistent clinical outcomes and predictabe MoAs. \nSo whether you’re part of a microbiome-focused biotech\, a pharmaceutical organization assessing this exciting field\, or an academic researcher with breakthrough findings\, join the Microbiome Movement as we explore the global advances in translational microbiome research\, and meet like-minded peers who are continuing to understand the causal and therapeutic potential of the ‘second genome’. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/5th-microbiome-movement-drug-development-summit-2020/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201002
DTEND;VALUE=DATE:20201003
DTSTAMP:20200924T135933Z
CREATED:20200824T155054Z
LAST-MODIFIED:20200924T135933Z
UID:4304-1601596800-1601683199@carb-x.org
SUMMARY:Boston Area Antimicrobial Resistance Network (BAARN) Meeting
DESCRIPTION:CARB-X speakers include Su Chiang\, Alliance Manager. \nThe 7th BAARN meeting will bring together the leading voices in academia and industry to addresss a defining global health crisis of our age: antibiotic resistant infection. \nThis year will be BAARN’s inaugural virtual meeting. We are using online platforms to present an amazing lineup of researchers and innovators\, accessible to anyone with an internet connection. The event will stream on YOUTUBE LIVE. Zoom and YouTube Live links will be sent upon registration. \nThis event is co-coordinated by the Harvard Microbial Sciences Initiative and the Harvard Infectious Disease Institute. \nTo learn more\, click here. \nTo register\, click here.
URL:https://carb-x.org/event/boston-area-antimicrobial-resistance-network-baarn-meeting/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T090000
DTEND;TZID=America/New_York:20200930T121500
DTSTAMP:20200924T134830Z
CREATED:20200908T153930Z
LAST-MODIFIED:20200924T134830Z
UID:4317-1601456400-1601468100@carb-x.org
SUMMARY:Longitude Prize Sprint Workshop: How to Attract Investment
DESCRIPTION:Recent CARB-X graduate\, Specific Diagnostics\, will be participating in this workshop. \nThis workshop will be a forum for start-up and SMEs developing diagnostic tests to: \n\nHear from successful entrepreneurs who have built diagnostic companies\, what do they think were their key factors for success?\nHear from venture capital investors about what they expect and need before making investments.\nMeet in small break-out sessions in which you will interact directly with other medtech startups who have built or are in midst of building their enterprises and share insights.\nParticipate in panel discussion where you can ask both medtech leaders and venture capital fund managers about the intricacies and nuances of dilutive fund raise.\n\nNote: this webinar is the second in the Longitude Prize Sprint series. \nMore details can be found on the Longitude Prize website here. Registration is limited\, if you have trouble registering please send an email to longitude.prize@nesta.org.uk \nTo view the agenda\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/longitude-prize-sprint-workshop-how-to-attract-investment/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200917T140000
DTEND;TZID=America/New_York:20200917T153000
DTSTAMP:20200916T133131Z
CREATED:20200916T133131Z
LAST-MODIFIED:20200916T133131Z
UID:4337-1600351200-1600356600@carb-x.org
SUMMARY:Building\, Funding\, and Growing Successful Biotech Startups
DESCRIPTION:Speakers include Cameron Bess\, Project Officer\, Antibacterials Branch\, Division of CBRN Medical Countermeasures\, BARDA. \nTurning a good scientific idea into a successful biotech startup is a challenging journey.This panel will highlight several successful paths that scientists can take toward creating a successful biotech company. Learn what New York-area resources are available to turn your idea into a business and help you develop entrepreneurial skills. \nThe event will introduce funding and strategic programs available from IndieBio\, the Center for Biotechnology\, the National Institutes of Health (NIH)\, and the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). \nSpeakers include: \n\nAnton Xavier\, Assistant Director of Technology and Business Development at the Center for Biotechnology.\nPhuong Nguyen\, Commercialization Fellow at the Center for Biotechnology.\nStephen Chambers\, Managing Director of IndieBio in New York.\nMatthew McMahon\, Director of NIH’s Small Business Education and Entrepreneurial Development (SEED) Program.\nCameron Bess\, Project Officer\, Antibacterials Branch\, Division of CBRN Medical Countermeasures\, BARDA.\n\nTo learn more and register\, click here. 
URL:https://carb-x.org/event/building-funding-and-growing-successful-biotech-startups/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR